Our previous studies revealed that WISP1 genetic polymorphisms were related to susceptibility and the platinum-based chemotherapy response of lung cancer, and we hypothesized that WISP1 polymorphisms may also be associated with the chemotherapy toxicity of lung cancer [19]. This evidence concerns the gene CCN4 and lung carcinoma.